Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Companies

Set Alert for Companies

Nanjing BioPoint Shoots For 2018 Double POC Launch; Seeks $10m

A China-based IVD company, spun out of an Australian medical research institute, is seeking investors to support its plans for the 2018 launch its first two point-of-care tests for patients with infectious diseases including HIV and viral hepatitis.

In Vitro Diagnostics Financing China
Advertisement

Latest From Companies

Stent Leaders Pull Out Of India Amidst Price Cap Storm; Opportunity For 'The Dragon'?

The storm in India over price caps on stents has not shown any signs of abating, with foreign firms seeking to pull back certain key brands and the pricing regulator resolute about maintaining market equilibrium. The slugfest also appears to have opened up the Indian market for Chinese firms, among others.

India Cardiovascular

BD, CR Bard Merger To Create Vascular Access Device Giant

Becton Dickinson has reached a definitive agreement to acquire CR Bard for $24bn. BD says Bard's product portfolio gives it a strong presence in fast-growing clinical areas and more reach outside the US while Bard expects to reach more customers by building on BD's leadership in medication management and infection prevention.

Companies Commercial

STAT-DX Aims To Take On Rival BioFire In Syndromic Testing

Barcelona start-up STAT-DX is gearing up to launch a new decentralized multiplex PCR system in the rapidly growing field of syndromic testing. The company, which will face larger rivals such as bioMérieux's BioFire, will unveil its new point-of-care platform at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in Vienna from 22-25 April.

Infectious Diseases In Vitro Diagnostics

Cellnovo Targets 2018 Launch Of Insulin Micropump With Artificial Pancreas Tech

Cellnovo has signed a commercial license agreement with digital health firm TypeZero to integrate its artificial pancreas software technology into Cellnovo’s digitally connected insulin patch pump. The integrated product is expected to launch in 2018.

Deals Diabetic Care

Imanova Seeks More Partners For Imaging-Aided Fight Against Neurodegen Disease

With another fresh injection of funds from the UK Medical Research Council, imaging services provider Imanova is advancing to the next stage of its MIND-MAPS program that aims to identify novel early markers of progression of neurodegenerative diseases, including Alzheimer's and Parkinson's. The data generated from the program could be used to help Imanova's pharma partners develop new therapies to tackle these diseases.

Neurology Diagnostic Imaging

Inside The Spinal Cord: InVivo Therapeutics Looks To Reverse Injury, Leverage Regulatory Reforms

InVivo Therapeutics is looking to build on a breakthrough in understanding the pathophysiology of spinal cord injury to bring the first device to market for partially reversing the debilitating condition. The firm is dealing with a cautious FDA in its pivotal-trial development, but also looking to leverage a new US policy for humanitarian-use devices to expedite its path to market expansion.

Neurology Innovation

M&A Analysis: No Spring For March Mergers

M&A deal activity waned in March, with a total of 9 deals completed in the month, down from 12 in February and 17 in March 2016. This third month brought the total number of deals for Q1 2017 to 33, a significant year-on-year decline compared to 51 in the first quarter of 2016.

M & A Deals

View Of The IVD Horizon: How Roche Diagnostics Sees The Sector Evolving

While the in vitro diagnostics landscape has seen players come and go, Roche Diagnostics has remained at the top. But the Swiss giant, like all its other smaller rivals, is facing a new reality, with increasing pressures to prove medical value, and a more stringent regulatory environment. Medtech Insight spoke to Roche Diagnostics' Jean-Claude Gottraux, head of centralized and point of care solutions, and Jean-Jacques Palombo, lifecycle leader for the company's cardiac, women's health and personalized health care solutions immunoassay portfolio, to gain their perspectives on how the sector has evolved and will continue to evolve. They also spoke about the company's strategy to address these changes and challenges.

In Vitro Diagnostics Business Strategies

Start-Up Spotlight: Origin Inc., Healing Diabetic Foot Ulcers With Nitric Oxide Plasma Tech

Nitric oxide plasma technology from US start-up Origin, Inc could hold the key to wound healing for patients suffering from chronic diabetic foot ulcers. Based on Nobel prize winning research, the privately-held company has developed a handheld, computer-guided system that generates NO from ambient room air within a defined plasma stream.

Wound Management Diabetic Care
See All
UsernamePublicRestriction

Register